CHINOOK THERAPEUTICS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2014 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Chinook Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2014 to Q2 2023.
  • Chinook Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$66.9M, a 77.8% decline year-over-year.
  • Chinook Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$246M, a 166% decline year-over-year.
  • Chinook Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$188M, a 82.5% decline from 2021.
  • Chinook Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$103M, a 26.1% decline from 2020.
  • Chinook Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$81.6M, a 75.5% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$246M -$66.9M -$29.3M -77.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 -$216M -$60.2M -$28.5M -89.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-08-07
Q4 2022 -$188M -$62.6M -$70.1M -929% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-27
Q3 2022 -$118M -$56M -$25.3M -82.4% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 -$92.5M -$37.6M +$4.92M +11.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$97.4M -$31.7M +$5.53M +14.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-08-07
Q4 2021 -$103M $7.55M +$57.5M Oct 1, 2021 Dec 31, 2021 10-K 2023-02-27
Q3 2021 -$160M -$30.7M -$11.9M -63.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$149M -$42.6M -$34.8M -450% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$114M -$37.2M -$32.1M -623% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$81.6M -$49.9M -$30.5M -157% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 -$51.1M -$18.8M +$2.14M +10.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$53.3M -$7.74M +$10.8M +58.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-08
Q1 2020 -$64.1M -$5.15M +$18.3M +78% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-08
Q4 2019 -$82.4M -$19.4M +$6.91M +26.2% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-09
Q3 2019 -$89.3M -$21M +$2.19M +9.48% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$91.5M -$18.6M +$5.82M +23.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-05
Q1 2019 -$97.3M -$23.4M -$1.93M -8.99% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-05
Q4 2018 -$95.4M -$26.3M -$189K -0.72% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-09
Q3 2018 -$95.2M -$23.1M +$1.37M +5.6% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-09
Q2 2018 -$96.5M -$24.4M -$5M -25.8% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-09
Q1 2018 -$91.5M -$21.5M +$318K +1.46% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-09
Q4 2017 -$91.9M -$26.1M +$3.44M +11.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$95.3M -$24.5M +$10.5M +30% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 -$106M -$19.4M -$21.7M -945% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 -$84.1M -$21.8M +$7.02M +24.3% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 -$91.1M -$29.6M -$32.7M -1054% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$58.5M -$35.1M -$35.6M -6282% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 -$22.9M $2.3M +$28.6M Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 -$51.4M -$28.8M -$12.2M -73.5% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 -$39.2M $3.1M +$4.02M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-01
Q3 2015 -$43.2M $567K +$5.25M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-01
Q2 2015 -$48.5M -$26.3M -$22.6M -624% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-01
Q1 2015 -$25.8M -$16.6M -$8.83M -113% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-01
Q4 2014 -$17M -$920K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-08
Q3 2014 -$4.68M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-08
Q2 2014 -$3.63M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-08
Q1 2014 -$7.78M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.